Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€11.60

€11.60

-0.390%
-0.045
-0.390%
€14.77

€14.77

 
18.04.24 / Tradegate WKN: A2QMYY / Symbol: HIMS / Name: Hims & Hers Health / Stock / ? /
Latest predictions
€18.55
10.04.24
-14.74%
buy
€20.00
19.03.24
-19.76%
buy
29.02.24
-2.15%
buy
€14.77
28.02.24
-4.96%
buy
€15.66
27.02.24
-8.34%
buy
€14.74
27.02.24
-8.34%
buy
Best running prediction
-
31.10.23
104.86%
buy
Your prediction

Hims & Hers Health Inc. Stock

Hims & Hers Health Inc. shows a slight decrease today, losing -€0.045 (-0.390%) compared to yesterday.
Hims & Hers Health Inc. is currently one of the favorites of our community with 12 Buy predictions and no Sell predictions.
With a target price of 14 € there is a positive potential of 20.74% for Hims & Hers Health Inc. compared to the current price of 11.6 €.

Pros and Cons of Hims & Hers Health Inc. in the next few years

Pros
?
M***** P*******
?
S********** s********
?
W********* I********* f** t** n*** y****
Cons
?
G***** c******* t* c**********
?
B****
?
C******** o* t** e**********
Tell us your opinion to access the 'Wisdom of the Crowds'

Comments

Prediction Buy
Perf. (%) -14.74%
Target price 18.548
Change
Ends at 10.04.25

Hims & Hers Health, Inc. (NYSE: HIMS) is now covered by analysts at Canaccord Genuity Group Inc.. They set a "buy" rating and a $20.00 price target on the stock.
Ratings data for HIMS provided by MarketBeat
Show more

Prediction Buy
Perf. (%) -4.96%
Target price 14.774
Change
Ends at 28.02.25

Hims & Hers Health, Inc. (NYSE: HIMS) was upgraded by analysts at Imperial Capital from an "in-line" rating to an "outperform" rating. They now have a $16.00 price target on the stock.
Ratings data for HIMS provided by MarketBeat
Show more

Prediction Buy
Perf. (%) -8.34%
Target price 15.662
Change
Ends at 27.02.25

Hims & Hers Health, Inc. (NYSE: HIMS) had its price target raised by analysts at Guggenheim from $15.00 to $17.00. They now have a "buy" rating on the stock.
Ratings data for HIMS provided by MarketBeat
Show more